Publication | Open Access

Recombinant IL-33 prolongs leflunomide-mediated graft survival by reducing IFN-γ and expanding CD4+Foxp3+ T cells in concordant heart transplantation

Cell TherapyConcordant Heart TransplantationTransplantationImmune RegulationImmunologyGraft SurvivalStem Cell TherapiesCell BiologyCd4+foxp3+ T CellsImmunotherapyMedicineCell TransplantationGraft Rejection